1. HBW Insight
  2. >>Health
  3. >>Business
  4. >>Marketing & Advertising

US Eroxon Launch In October Will Mark Haleon’s First Foray Into Sexual Health

 
• By David Ridley

Haleon will launch Futura Medical's FDA-approved OTC medical device for erectile dysfunction in the US before the end of the year. Already available to pre-order online on Amazon, Eroxon represents the firm's first move into the sexual health category. 

• Source: Shutterstock

Haleon plc will launch Futura Medical plc’s drug-free erectile dysfunction gel Eroxon online and in “most major retailers” in the US in October. Available now for pre-order at Amazon, Eroxon will be Haleon's first offering in the sexual health space.

“We are proud to take this bold step to make this first-of-its-kind OTC gel treatment accessible to the millions of...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on HBW Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Marketing & Advertising

EU Green Claims Directive: Commission Says It ‘Has Not Withdrawn’ From Negotiations

 
• By David Ridley

What's going on with the EU Green Claims Directive? HBW Insight speaks to the European Commission, Parliament and Council to find out why trilogue negotiations seem to have stalled.

Scope Launches Eyelid-Friendly Eye Cream In The UK

 
• By David Ridley

Eyelids have the "thinnest, most sensitive skin on the body" and are "highly prone to dehydration," which is why Scope has launched new Optase Life Sensitive Eye Daily Renewal Cream.

P&G’s Crest Gum Detoxify Ad Claims Rinsed Clean In NAD Review On GuruNanda Challenge

 
• By Malcolm Spicer

P&G provided sufficient support for all challenged claims, including the “Gum Detoxify” brand used on the product label and in advertising on the website and in magazine detail pages.

German Associations Call For EU Green Claims Directive Trilogue Suspension

 
• By David Ridley

Pharma Deutschland is one of 21 German associations calling for trilogue negotiations in relation to the EU Green Claims Directive to be suspended while a “comprehensive and independent written impact assessment” is undertaken.

More from Business

Softness In US And China Holds Back Bayer Consumer Health

 
• By Tom Gallen

Like its peers, Bayer Consumer Health has struggled in the challenging US market in the first half of 2025 and says it doesn't expect conditions to change this year.

Repeat Buyers Passing 50% Key For Opill Sales Leading Perrigo’s Women’s Health Growth

 
• By Malcolm Spicer

“We continue to grow the brand. It was slower than initially anticipated or forecasted in basis, but I'm pleased with how it's developing,” says CEO Patrick Lockwood-Taylor of Opill performance.

Recordati Benefits From Cough & Cold Rebound

 
• By Tom Gallen

OTC sales grew at Italy's Recordati in the first half of 2025, with an improving cough and cold picture contributing to the rise.